Related Experiment Video

Updated: Aug 21, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Antagonism of Myc functions by Arf

John L Cleveland1, Charles J Sherr

  • 1Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Cancer Cell
|October 19, 2004
PubMed

Insights

The Arf-Mdm2-p53 tumor suppressor pathway uses p19(Arf) to block cell proliferation. This protein binds to Myc oncoproteins, inhibiting their function and providing a new feedback mechanism in cancer suppression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Regulation

Background:

  • The Arf-Mdm2-p53 pathway is a critical tumor suppressor mechanism.
  • This pathway responds to hyperproliferative signals driven by oncoproteins like Myc.
  • Understanding feedback loops within this pathway is crucial for cancer research.

Purpose of the Study:

  • To investigate novel feedback control mechanisms in the Arf-Mdm2-p53 pathway.
  • To elucidate the interaction between p19(Arf) and Myc.
  • To determine how this interaction affects cell proliferation.

Main Methods:

  • Investigated protein-protein interactions between p19(Arf) and Myc.
  • Assessed the impact of p19(Arf) binding on Myc's transactivation functions.
  • Monitored effects on cell proliferation in response to induced p19(Arf).

Main Results:

  • p19(Arf) was found to bind directly to Myc.
  • This binding event selectively impaired Myc's ability to activate gene transcription.
  • Induced p19(Arf) effectively blocked Myc-driven cell proliferation.

Conclusions:

  • A new feedback loop involving p19(Arf) and Myc has been identified.
  • p19(Arf) acts as a direct inhibitor of Myc's oncogenic functions.
  • This interaction represents a potential therapeutic target for Myc-driven cancers.

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Aip1p Dynamics Are Altered by the R256H Mutation in Actin08:57

Aip1p Dynamics Are Altered by the R256H Mutation in Actin

Published on: July 30, 2014

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...